NA
CABA icon

NewEdge Advisors’s Cabaletta Bio CABA Stock Holding History

NewEdge Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,250
Closed -$9.65K – 3984
2024
Q4 		$9.65K Buy
+4,250
New +$14.9K ﹤0.01% 3045
2023
Q1 		– Sell
-140
Closed -$1.29K – 3519
2022
Q4 		$1.29K Buy
+140
New +$510 ﹤0.01% 2958

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors's CABA Position: Q1 2025 in Review

NewEdge Advisors sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 4,250 shares — an estimated $9.65K sold.

NewEdge Advisors first reported a position in CABA in Q4 2022 and held it in 2 quarters. The position peaked at $9.65K in Q4 2024. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • NewEdge Advisors reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • NewEdge Advisors sold 4,250 Cabaletta Bio shares in Q1 2025, an estimated $9.65K.
  • NewEdge Advisors first reported a position in Cabaletta Bio in Q4 2022 and held it in 2 quarters.
  • NewEdge Advisors's Cabaletta Bio position peaked at $9.65K in Q4 2024.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on NewEdge Advisors's 13F filing for Q1 2025, filed 15 May 2025.